CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,942,971 | -26.9% | 108,900 | -9.6% | 0.00% | 0.0% |
| Q2 2023 | $6,759,256 | +318.6% | 120,400 | +237.3% | 0.00% | +100.0% |
| Q1 2023 | $1,614,711 | -57.2% | 35,700 | -61.5% | 0.00% | -50.0% |
| Q4 2022 | $3,772,320 | -72.2% | 92,800 | -55.4% | 0.00% | -66.7% |
| Q3 2022 | $13,586,000 | -19.1% | 207,900 | -24.7% | 0.01% | -14.3% |
| Q2 2022 | $16,785,000 | – | 276,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 225 | $1,060,000 | 0.10% |
| GROUP ONE TRADING, L.P. | 9,500 | $447,000 | 0.00% |
| SIMPLEX TRADING, LLC | 278 | $1,309,000 | 0.00% |
| JPMORGAN CHASE & CO | 31,900 | $1,447,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |